Cargando…
Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer
Despite advances in colon cancer research and novel therapies, high risk of recurrence remains a major challenge. This study reports miRNA expression profiling as a biomarker for the prognosis of TNM stage II and III colon cancer. Fresh frozen biopsies from the study cohort (N=111) were analyzed for...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675676/ https://www.ncbi.nlm.nih.gov/pubmed/29152124 http://dx.doi.org/10.18632/oncotarget.21237 |